Study Shows Cisplatin Combined with High-Dose Brachytherapy for Advanced Cervical Cancer May Be More Beneficial
American Society for Radiation Oncology (ASTRO)Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also indicated that the combined treatments produced acceptable levels of toxicity.